The results revealed that compared with normal tissues, WWP2 was significantly up-regulated in four tumor types: liver hepatocellular carcinoma (LIHC), cholangiocarcinoma (CHOL), prostate cancer (PRAD), and stomach adenocarcinoma (STAD). This evidence concerns the gene WWP2 and Familial prostate cancer.